Britain will start to roll out Merck's molnupiravir COVID-19 antiviral pill through a drug trial later this month, Susan Hopkins, Chief Medical Adviser at the UK Health Security Agency said on Sunday.
Asked about the molnupiravir approval, Hopkins told BBC television: "That is great news and it will start to be rolled out through a drug trial in the end of this month/the beginning of December."
Hopkins said all the trials so far had been done with the unvaccinated, so this would help understand how it will work in the wider vaccinated population. "The new Pfizer drug is probably not going to be licensed until the new year some time," she added. "It is still likely to be a couple of months away."Sign up for our newsletter
Subscribe for our daily curated newsletter to receive the latest exclusive Reuters coverage delivered to your inbox.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
UK to roll out Covid-19 antiviral drug trial this month – latest updatesUK to roll out Covid19 antiviral drug trial this month. Other updates: 🇦🇺 Sydney to further ease Covid-19 curbs 🇷🇺 Russia reports 1,178 Covid deaths 🇺🇸 Airlines gear up for travel surge as US reopens Read more:
Baca lebih lajut »
Covid-19: US reopens border to UK travellers after almost two yearsAfter nearly two years, the US lifts its travel ban to UK visitors who have had both Covid vaccine doses.
Baca lebih lajut »
Japan has zero daily COVID-19 deaths for first time in 15 months - mediaJapan recorded no daily deaths from COVID-19 for the first time in more than a year on Sunday, according to local media.
Baca lebih lajut »
'An unprecedented departure': Unvaccinated workers face new challenge paying for their COVID-19 testingUnvaccinated workers calculate the costs of regular COVID testing — Biden administration sets Jan. 4 vaccination deadline for workers
Baca lebih lajut »
Covid-19 Vaccines and Myocarditis Link Probed by ResearchersResearchers investigating rare heart-related risks linked to Covid-19 vaccines are exploring several emerging theories, including one centered on the spike protein made in response to the shots
Baca lebih lajut »